9/3/26 16:54 | 9/1/26 | CATX | Perspective Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lantheus Holdings, Inc. | MA | T | | 2 | S | -357 | 3.14 | 0 | -114 | | 11,599 | D | | | | | | | | | | | | | | |
8/27/26 17:27 | 8/20/26 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gary M. Huff | CA | D | | 1 | P | 50 | 1.60 | 0 | 31 | 156 | 51 | D | | | | | | | | | | | | | | |
8/27/26 17:26 | 8/26/26 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moatazedi David | CA | D | | 1 | P | 16 | 1.60 | 0 | 10 | 33 | 41 | D | | | | | | | | | | | | | | |
8/27/26 17:26 | 8/26/26 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Chin Eric | CA | D | | 1 | P | 10 | 1.60 | 0 | 6 | 19 | 39 | D | | | | | | | | | | | | | | |
8/27/26 17:24 | 8/26/26 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Barbieri Allen | CA | DO | Exec Vic | 1 | P | 32 | 1.60 | 0 | 20 | 37 | 74 | D | | | | | | | | | | | | | | |
8/27/26 17:23 | 8/26/26 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | 1 | P | 50 | 1.60 | 0 | 31 | 15 | 243 | D | | | | | | | | | | | | | | |
8/24/26 17:00 | 8/20/26 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Emerson Andrew | ME | O | EVP,CFO, | 1 | M.d | 47 | 178.26 | 0 | 0 | 6 | 4 | D | | | | | | | | | | | | | | |
8/24/26 16:05 | 8/20/26 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | 1 | S.m | -287 | 12.65 | 0 | -23 | | 1,205 | D | | | | | | | | | | | | | | |
8/21/26 16:30 | 8/19/26 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | D | | 1 | S | -175 | 8.49 | 0 | -21 | | 209 | D | | | | | | | | | | | | | | |
8/18/26 16:14 | 8/15/26 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Hanson Bryan Michael | CA | O | EVP Glob | 2 | M.d | 0 | 0.00 | 0 | 6 | 345 | 8 | D | | | | | | | | | | | | | | |
8/6/26 08:16 | 8/4/26 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Nassif Mikheal | MI | DO | CEO | 1 | P | 4 | 11.81 | 0 | 0 | 53 | 1 | I | | | | | | | | | | | | | | |
7/24/26 17:26 | 7/2/26 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dulac Edward J III | MA | O | EVP,CFO | 2 | S | -175 | 13.72 | 0 | -13 | | 156 | D | | | | | | | | | | | | | | |
7/6/26 17:02 | 7/1/26 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dube Michael P | MA | O | VP,Chief | 1 | S | -44 | 16.78 | 0 | -3 | | 67 | D | | | | | | | | | | | | | | |
6/22/26 08:33 | 6/18/26 | ICCC | Immucell Corp /De/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Te Boekhorst Paul Francis Olivier | ME | DO | P,CEO | 1 | P | 76 | 9.50 | 0 | 8 | 82 | 18 | D | | | | | | | | | | | | | | |
6/9/26 16:53 | 6/5/26 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | TX | T | | 1 | P.d | 100 | 0.4500 | 0 | 222 | 6 | 4,053 | I | | | | | | | | | | | | | | |
6/9/26 16:20 | 6/8/26 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Kumar Rashmi | UT | D | | 1 | S | -67 | 4.46 | 0 | -15 | | 172 | D | | | | | | | | | | | | | | |